Estrogen is associated with improved survival in aging women with congestive heart failure: analysis of the vesnarinone studies
Steven E. Reis, MD, FACC*,
Richard Holubkov, PhD*,
James B. Young, MD, FACC ,
B. G. White, PhD ,
Jay N. Cohn, MD, FACC and
Arthur M. Feldman, MD, PhD, FACC*
* University of Pittsburgh, Pittsburgh, Pennsylvania, USA
Cleveland Clinic Foundation, Cleveland, Ohio, USA
Clinical Cardiovascular Research, Gaithersburg, Maryland, USA
University of Minnesota, Minneapolis, Minnesota, USA

View larger version (15K):
[in a new window]
|
Figure 1 Kaplan-Meier curves for all-cause mortality according to estrogen use (p = 0.004). Solid line = estrogen nonusers; broken line = estrogen users.
|
|

View larger version (13K):
[in a new window]
|
Figure 2 Kaplan-Meier curves for all-cause mortality for estrogen users according to type of hormone (p = 0.42). Solid line = estrogen alone; broken line = estrogen/progestin.
|
|
|